These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2145846)

  • 1. Dopaminergic activity and stereochemical considerations for rigid angular tricyclic congeners of dopamine: benzoquinoxalines and naphthothiazines.
    Perrone R; Berardi F; Tortorella V; Racagni G; Rovescalli A
    Farmaco; 1990 May; 45(5):479-88. PubMed ID: 2145846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and dopamine receptors binding affinity of 2-(3-fluoro-4-hydroxyphenyl)ethylamine and its N-alkyl derivatives.
    Cardellini M; Cingolani GM; Claudi F; Perlini V; Balduini W; Cattabeni F
    Farmaco Sci; 1988 Jan; 43(1):49-59. PubMed ID: 2899520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor agonists: new angularly annulated tricyclic compounds.
    Perrone R; Berardi F; Bettoni G; Tortorella V
    Farmaco Sci; 1988 Jan; 43(1):61-9. PubMed ID: 3396689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives.
    Claudi F; Cingolani GM; Giorgioni G; Cattabeni F; Cimino M; Di Luca M
    Drug Des Deliv; 1989 Jun; 4(4):279-87. PubMed ID: 2570592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
    Seiler MP; Markstein R
    Mol Pharmacol; 1982 Sep; 22(2):281-9. PubMed ID: 7144729
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of new linearly annulated tricycles as rigid dopamine congeners.
    Perrone R; Berardi F; Bettoni G; Tortorella V
    Farmaco Sci; 1988 Jan; 43(1):71-7. PubMed ID: 3396690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Link between dopamine D1 and D2 receptors in rat and human striatal tissues.
    Seeman P; Tallerico T
    Synapse; 2003 Mar; 47(4):250-4. PubMed ID: 12539197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
    Cooper DM; Bier-Laning CM; Halford MK; Ahlijanian MK; Zahniser NR
    Mol Pharmacol; 1986 Feb; 29(2):113-9. PubMed ID: 3005824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
    Hilakivi I; Rinne J; Marjamäki P
    Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors.
    McGonigle P; Boyson SJ; Reuter S; Molinoff PB
    Synapse; 1989; 3(1):74-82. PubMed ID: 2521960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
    Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
    Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems.
    Sonsalla PK; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1986 Sep; 238(3):932-7. PubMed ID: 2943891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the dopaminergic receptor system after chronic administration of cocaine.
    Alburges ME; Narang N; Wamsley JK
    Synapse; 1993 Aug; 14(4):314-23. PubMed ID: 8161369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of a complex subunit composition of a unitary dopamine receptor: effects of lesions and proteolytic enzymes on stereospecific binding.
    Leysen JE; Gommeren W; Van Gompel P
    Adv Biochem Psychopharmacol; 1983; 36():147-62. PubMed ID: 6858752
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of some 2-hydroxybenzylpiperidines with dopamine receptors.
    Cardellini M; Claudi F; Perlini V; Balduini W; Cattabeni F; Cimino M
    Farmaco Sci; 1987 Apr; 42(4):307-17. PubMed ID: 3595841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptors and cyclic AMP in rabbit retina: a pharmacological and stereochemical analysis using semi-rigid analogs of dopamine (aminotetralins) and thioxanthene isomers.
    Schorderet M; McDermed J; Magistretti P
    J Physiol (Paris); 1978; 74(5):509-13. PubMed ID: 217999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.